Clinical Trials Sponsored by Intellectual Ventures

Total 232 results

University of California, San Francisco
Makerere University; Infectious Diseases Research Collaboration, Uganda; Intellectual...

Terminated

A Feasibility Study Evaluating a Novel Mask (Nasal Reservoir Cannula)

Pneumonia Childhood

Uganda
LED Intellectual Properties, LLC

Unknown

A Controlled Study to Investigate the Effect of Multi-wave Light Emitting Diode (LED) Bed on Blood Pressure and Endothelial Function

Hypertension

United States
Thayer Intellectual Property, Inc.

Terminated

Evaluation of the MANOS Carpal Tunnel Release System in Patients With Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

United States
Fontem Ventures BV

Completed

A Study to Evaluate the Safety of Electronic Vapor Products for 2 Years

Healthy Volunteers

United Kingdom
Fontem Ventures BV

Completed

A Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes With Nicotine Salt Formulations

Healthy Volunteers

United States
Fontem Ventures BV

Completed

A Study to Assess Tobacco-related Biomarkers of Exposure in Smokers Using myBlu E-cigarettes

Healthy Volunteers

United States
Roman Health Ventures Inc.

Recruiting

Blood Specimen Collection For Laboratory Assay Research

Sexual Dysfunction | Pathology | Hair Loss | General; Metabolic Disorder

United States
Aarhus University Hospital
Ferring Ventures

Completed

Gag-layer in the Urothelium of the Human Upper Urinary Tract

Bladder Cancer | Renal Cancer

Denmark
Real Time Diagnostics Ventures INC

Withdrawn

Hemp-Derived Botanical Dietary Supplementation During Recovery From Brain Injury

Traumatic Brain Injury
Aventure AB

Active, not recruiting

Evaluation of an Herbal Extract on Sleep Parameters

Sleep Onset Latency

Sweden
Aventure AB

Completed

Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response

Blood Glucose Response

Sweden
Aventure AB

Completed

Evaluation of Postprandial Glycaemia in a Healthy Population After Intake of Milk and Oat Based Products

Healthy

Sweden
Fontem US LLC

Active, not recruiting

Nicotine Uptake and Abuse Liability Assessments of 5 Blu Disposable Electronic Cigarettes in Comparison to a Combustible Cigarette

Healthy Volunteers

United States
Fontem US LLC
Fontem Ventures BV

Completed

A Study to Evaluate Nicotine Uptake and Biomarkers in Smokers Using mybluTM Electronic Cigarettes

Healthy Volunteers

United States
Fontem US LLC
Fontem Ventures BV

Completed

A Study to Evaluate Nicotine Uptake and Biomarkers in Adult Smokers Using mybluTM Electronic Cigarettes

Healthy Volunteers

United States
Medtronic Corporate Technologies and New Ventures

Completed

Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis. (MiD)

End Stage Renal Disease

United States, India
Medtronic Corporate Technologies and New Ventures

Completed

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C (COPE-HCV)

Hepatitis C

United States
Veyl Ventures LLC
KGK Science Inc.

Completed

The Safety and Efficacy of a Bone Broth Diet on Weight Loss in Obese Adults

Weight Loss

Canada
SerenaGroup, Inc.
MDM Wound Ventures, LLC

Completed

The Effectiveness of a Mechanical Debridement Instrument in Reducing Bioburden in Chronic Wounds

Chronic Wounds | Acute Wounds

United States
Molex Ventures LLC
University of Virginia

Suspended

Pilot Study of the FEEDBACK System for Use With Infants in the Neonatal Intensive Care Unit at University of Virginia

Breastfeeding

United States
Medtronic Corporate Technologies and New Ventures

Completed

Gastric Electrical Stimulation (GES) for the Treatment of Obesity (GES)

Obesity

Netherlands, United States
Medtronic Corporate Technologies and New Ventures

Completed

Medtronic Genetic Arrhythmia Markers for Early Detection (GAME Study) (GAME)

Atrial Fibrillation | Ventricular Fibrillation | Tachycardia | Death, Sudden, Cardiac | Sick Sinus Syndrome

United States
Medicines for Malaria Venture

Completed

Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.

Uncomplicated Plasmodium Falciparum Malaria

Uganda, Benin, Burkina Faso, Congo, The Democratic Republic of the, Gabon, Mozambique, Vietnam
Medicines for Malaria Venture

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects

Healthy Volunteers | Malaria Falciparum | Malaria Vivax

United States
Medicines for Malaria Venture

Completed

A Dose-escalation Study to Investigate Safety and Toleration of OZ439

Malaria

United Kingdom
Medicines for Malaria Venture

Completed

Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers. (PedPQP(BA/FE))

Malaria

Tanzania
Medicines for Malaria Venture

Completed

Absolute BA and OZ439 PK Effect of Different OZ439 Dose Volumes and Cobicistat Co-administration Study

Malaria

Netherlands
Medicines for Malaria Venture

Completed

OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observation

Malaria

Thailand
Medicines for Malaria Venture

Completed

A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route

Healthy Volunteers

United Kingdom
New Age Ventures LLC
KGK Science Inc.

Completed

A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population

Healthy | Cannabis

Canada
Oregon Health and Science University
Arnold Ventures

Not yet recruiting

The Over The Counter Pill National Study

Contraception | Contraception Behavior | Health Care Utilization | Contraceptive Usage
Augusta University
Funding source: Pruvit Ventures, Inc

Completed

Effects of Exogenous Ketones in Healthy Young Adults

Healthy Young Adults

United States
GlaxoSmithKline
Medicines for Malaria Venture

Recruiting

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

Malaria, Falciparum

United Kingdom
Sanofi
Medicines for Malaria Venture

Completed

Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria

Plasmodium Falciparum Infection

Benin, Burkina Faso, Gabon, Kenya, Uganda
GlaxoSmithKline
Medicines for Malaria Venture

Completed

Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria

Malaria, Vivax

Indonesia
Medicines for Malaria Venture
AbbVie

Completed

Malaria: Relative Bioavailability and Food Effect of DSM265

Healthy Volunteers

United States
GlaxoSmithKline
Medicines for Malaria Venture

Completed

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

Malaria, Vivax

United States
GlaxoSmithKline
Medicines for Malaria Venture

Completed

A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

Malaria, Vivax

United States
GlaxoSmithKline
Medicines for Malaria Venture

Completed

Tafenoquine/Chloroquine DDI Study

Malaria

United States
GlaxoSmithKline
Medicines for Malaria Venture

Completed

G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)

Malaria

Thailand
GlaxoSmithKline
Medicines for Malaria Venture

Completed

Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria

Malaria, Vivax

Thailand, Vietnam, Colombia, Brazil, Ethiopia, Peru
GlaxoSmithKline
Medicines for Malaria Venture

Completed

Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse

Malaria, Vivax

Thailand, India, Brazil, Ethiopia, Peru, Bangladesh, Cambodia, Philippines
Medicines for Malaria Venture
AbbVie

Terminated

Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects

Healthy Volunteers | Bioavailability

United States
Sanofi
Medicines for Malaria Venture

Terminated

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria (FALCI)

Plasmodium Falciparum Infection

Benin, Burkina Faso, Gabon, Kenya, Mozambique, Uganda, Vietnam
GlaxoSmithKline
Medicines for Malaria Venture

Completed

A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria

Malaria, Vivax

Vietnam, Colombia
Daisy Pharma Opioid Venture, LLC

Unknown

Dronabinol Opioid Sparing Evaluation (DOSE) Trial

Chronic Pain

United States
GlaxoSmithKline
Medicines for Malaria Venture

Completed

Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects

Malaria

United Kingdom
Sanofi
Medicines for Malaria Venture

Completed

Artesunate Plus Amodiaquine in Malaria in Cote d'Ivoire

Malaria

Côte D'Ivoire
San Diego Veterans Healthcare System
Inflammagen/Leading Ventures

Terminated

Single Dose Enteral Tranexamic Acid in Critically Ill Patients

Sepsis | Shock | Critical Illness | Hypotension

United States
Fundação Altino Ventura

Completed

Cataract Surgery With Intracameral Triamcinolone in Infants

Cataract

Brazil

Clinical Trials Sponsored by Intellectual Ventures

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations